NO20042630L - Tablettert, oral, enterisk belagt, farmasoytisk doseringsform inneholdende en syrelabil benzimidazol - Google Patents

Tablettert, oral, enterisk belagt, farmasoytisk doseringsform inneholdende en syrelabil benzimidazol

Info

Publication number
NO20042630L
NO20042630L NO20042630A NO20042630A NO20042630L NO 20042630 L NO20042630 L NO 20042630L NO 20042630 A NO20042630 A NO 20042630A NO 20042630 A NO20042630 A NO 20042630A NO 20042630 L NO20042630 L NO 20042630L
Authority
NO
Norway
Prior art keywords
dosage form
pharmaceutical dosage
oral
tablets
acid labile
Prior art date
Application number
NO20042630A
Other languages
English (en)
Norwegian (no)
Inventor
Antonio Lopez Cabrera
Javier Lizcano Garcia
Jaume Sangra Perez
Pere Joan Solanas Lbarra
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/ES2002/000539 external-priority patent/WO2003057692A1/es
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of NO20042630L publication Critical patent/NO20042630L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20042630A 2001-12-18 2004-06-23 Tablettert, oral, enterisk belagt, farmasoytisk doseringsform inneholdende en syrelabil benzimidazol NO20042630L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200102820A ES2198195B1 (es) 2001-12-18 2001-12-18 Forma de dosificacion farmaceutica oral comprimida, con recubrimiento enterico, que contiene un compuesto de bencimidazol labil en medio acido.
PCT/ES2002/000539 WO2003057692A1 (es) 2001-12-11 2002-11-19 Nuevas formas cristalinas del meloxicam y procedimientos para su preparacion e interconversion

Publications (1)

Publication Number Publication Date
NO20042630L true NO20042630L (no) 2004-08-13

Family

ID=8499777

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042630A NO20042630L (no) 2001-12-18 2004-06-23 Tablettert, oral, enterisk belagt, farmasoytisk doseringsform inneholdende en syrelabil benzimidazol

Country Status (19)

Country Link
US (1) US7217429B2 (de)
EP (1) EP1464331B9 (de)
JP (1) JP4523278B2 (de)
KR (1) KR100877649B1 (de)
AT (1) ATE410149T1 (de)
AU (1) AU2002350750B2 (de)
CA (1) CA2470609C (de)
DE (1) DE60229295D1 (de)
DK (1) DK1464331T3 (de)
ES (2) ES2198195B1 (de)
HR (1) HRP20040596A2 (de)
HU (1) HUP0402488A3 (de)
IL (2) IL162544A0 (de)
MX (1) MXPA04005902A (de)
NO (1) NO20042630L (de)
NZ (1) NZ533886A (de)
PT (1) PT1464331E (de)
WO (1) WO2003051342A1 (de)
ZA (1) ZA200405078B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
ES2278511B1 (es) * 2005-07-28 2008-06-16 Laboratorios Almirall S.A. Comprimidos con perfil de disolucion mejorado.
WO2007100984A2 (en) * 2006-02-24 2007-09-07 Allergan, Inc. Beads containing pyridin-sulfinyl benzoimidazole sulfonyl phenoxy acetate derivatives
WO2010078541A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
US8377475B2 (en) * 2009-01-05 2013-02-19 Mcneil-Ppc, Inc. Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer
US8246988B2 (en) * 2009-01-05 2012-08-21 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
WO2010117756A2 (en) * 2009-03-31 2010-10-14 Dr. Reddy's Laboratories Ltd Substituted benzimidazole pharmaceutical formulations
EP2345408A3 (de) * 2010-01-08 2012-02-29 Dr. Reddy's Laboratories Ltd. Säurelabile Arzneimittelformulierungen
US20130122090A1 (en) * 2010-07-22 2013-05-16 Lupin Limited Multiple Unit Tablet Composition
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
DK1078628T3 (da) * 1994-07-08 2009-02-23 Astrazeneca Ab Tabletteret flerenhedsdoseringsform
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
ES2094694B1 (es) 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
ATE286394T1 (de) * 1995-09-21 2005-01-15 Pharma Pass Ii Llc Ein säurelabile omeprazol enthaltende arzneizusammensetzung und verfahren zu deren herstellung
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE9700885D0 (sv) * 1997-03-12 1997-03-12 Astra Ab New pharmaceutical formulation
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
JP2002363080A (ja) * 2001-06-08 2002-12-18 Towa Yakuhin Kk 安定な内服用抗潰瘍製剤の製造法

Also Published As

Publication number Publication date
NZ533886A (en) 2005-12-23
EP1464331B1 (de) 2008-10-08
ES2315416T3 (es) 2009-04-01
EP1464331A1 (de) 2004-10-06
JP2005523884A (ja) 2005-08-11
ES2198195B1 (es) 2004-10-01
JP4523278B2 (ja) 2010-08-11
MXPA04005902A (es) 2004-09-13
KR100877649B1 (ko) 2009-01-12
CA2470609A1 (en) 2003-06-26
US7217429B2 (en) 2007-05-15
ZA200405078B (en) 2005-06-27
ATE410149T1 (de) 2008-10-15
PT1464331E (pt) 2008-11-19
HRP20040596A2 (en) 2004-10-31
DE60229295D1 (de) 2008-11-20
US20030118650A1 (en) 2003-06-26
DK1464331T3 (da) 2009-01-05
HUP0402488A2 (hu) 2005-05-30
KR20040079906A (ko) 2004-09-16
IL162544A0 (en) 2005-11-20
ES2198195A1 (es) 2004-01-16
CA2470609C (en) 2010-09-28
EP1464331B9 (de) 2009-10-14
HUP0402488A3 (en) 2009-09-28
WO2003051342A1 (es) 2003-06-26
AU2002350750A1 (en) 2003-06-30
AU2002350750B2 (en) 2008-10-16
IL162544A (en) 2010-04-29

Similar Documents

Publication Publication Date Title
JP4818516B2 (ja) 化合物の抗菌剤としての新規な使用
DK1086694T3 (da) Oral farmaceutisk formulering i fast form med modificeret frigivelse, der indeholder en syrelabil benzimidazolforbindelse
DK1464331T3 (da) Komprimeret, oral, farmaceutisk doseringsform med en enterisk coating, der indeholder en syrelabil benzimidazolforbindelse
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
SE9600072D0 (sv) New oral formulation of two active ingredients II
ATE261303T1 (de) Neues ein säureempfindliches benzimidazol enthaltendes mittel und verfahren zu dessen herstellung
SE9600070D0 (sv) New oral pharmaceutical dosage forms
MX9706785A (es) Formas de dosificacion farmaceutica oral que comprenden un inhibidor de la bomba de protones y un agente antiacido o alginato.
EE03305B1 (et) Paljuosaline tableteeritud annusvorm I
MX9604354A (es) Nueva forma de dosis farmaceutica oral.
DE69636104D1 (de) Orale pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreigabe von Protonenpumpen-Hemmern
DE69909316D1 (de) Pharmazeutische formulierung mit omeprazol
MA25567A1 (fr) Nouvelle composition et son utilisation
AR034517A1 (es) Formulacion farmaceutica
SK165598A3 (en) Use of h+,k+ -atpase inhibitor, pharmaceutical composition containing the same and its use
SE9700885D0 (sv) New pharmaceutical formulation
WO2002069968A8 (en) New use
TH22304A (th) สารเตรียมทางเภสัชกรรมแบบหลายหน่วยที่มีสารยัยยั้งปั๊มโปรตอน
RU96107097A (ru) Составная единичная дозированная форма в виде таблетки, содержащая ингибитор протонного насоса
UY27345A1 (es) Formulación farmacéutica.
RU97116725A (ru) Сложные шипучие лекарственные формы, включающие ингибитор протонного насоса
TH105539A (th) รูปแบบยาของแข็งซึ่งมีออลเมซาร์แทนเมโดโซมิลและแอเซลนิไดพีน

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application